Chris Williams

Chris Williams

Directeur des opérations chez CYTEK BIOSCIENCES, INC.

Fortune : 55 748 $ au 30/04/2024

55 ans
Health Technology
Consumer Services

Provenance du réseau au premier degré de Chris Williams

EntitéType d'entitéIndustrie
Public Company Medical Specialties 14

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Chris Williams via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
BIOGEN INC. Pharmaceuticals: Major

Gisele Dion

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Jack Ball

Corporate Officer/Principal

EXACT SCIENCES CORPORATION Medical Specialties

Donnie Hardison

Chief Executive Officer

STANDARD BIOTOOLS INC. Medical Specialties

Valerie Barnett

Corporate Officer/Principal

Medical Specialties

Allen Poirson

Chairman

Electrical Products

Wen Bin Jiang

Founder

Biotechnology

Jack Ball

Chief Executive Officer

Medical Specialties

Jack Ball

Director/Board Member

Biotechnology

Jack Ball

Director/Board Member

Biotechnology

Allen Poirson

Philippe Busque

Chief Executive Officer

Sales & Marketing

SHIRE Pharmaceuticals: Major

Gisele Dion

Comptroller/Controller/Auditor

Biotechnology

Jack Ball

Director/Board Member

Medical Specialties

Jack Ball

Director/Board Member

Miscellaneous Commercial Services

Jack Ball

Director/Board Member

Pharmaceuticals: Major

Jack Ball

Director/Board Member

Stanford University College/University

Allen Poirson

Doctorate Degree

TAKEDA PHARMACEUTICAL COMPANY LIMITED Pharmaceuticals: Major

Gisele Dion

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Valerie Barnett

General Counsel

City University of New York College/University

Ming Yan

Doctorate Degree

Fairfield University College/University

Gisele Dion

Undergraduate Degree

Park University College/University

Melik Ulusu

Masters Business Admin

University of California, Irvine College/University

Valerie Barnett

Undergraduate Degree

University of California, Santa Barbara College/University

Wen Bin Jiang

Doctorate Degree

University of Georgia College/University

Jack Ball

Undergraduate Degree

University of Iowa College/University

Connie Wedel

Undergraduate Degree

University of Montréal College/University

Philippe Busque

Doctorate Degree

Biotechnology

Deborah Neff

Vera Imper

Philippe Busque

President

Corporate Officer/Principal

Sales & Marketing

University of Zagreb College/University

Vera Imper

Doctorate Degree

Istanbul Technical University College/University

Melik Ulusu

Undergraduate Degree

Fudan University College/University

Wen Bin Jiang

Ming Yan

Graduate Degree

Undergraduate Degree

Electronic Equipment/Instruments

Jack Ball

Director/Board Member

Semiconductors

Wen Bin Jiang

Chief Tech/Sci/R&D Officer

DERMIRA, INC. Pharmaceuticals: Major

Valerie Barnett

General Counsel

INHIBIKASE THERAPEUTICS, INC. Pharmaceuticals: Major

Gisele Dion

Director/Board Member

Miscellaneous Commercial Services

Jack Ball

President

Cornell Law School College/University

Valerie Barnett

Graduate Degree

ILR School College/University

Connie Wedel

Masters Business Admin

Drugstore Chains

Allen Poirson

Corporate Officer/Principal

Biotechnology

Jack Ball

Director/Board Member

Pharmaceuticals: Major

Gisele Dion

Comptroller/Controller/Auditor

Investment Managers

Allen Poirson

Private Equity Investor

Abbott

Philippe Busque

Corporate Officer/Principal

Miscellaneous Commercial Services

Jack Ball

Director/Board Member

Biotechnology

Jack Ball

Director/Board Member

Statistiques

Internationale

Etats-Unis 42
Canada 3
Suède 2
Irlande 2
Japon 2

Sectorielle

Health Technology 21
Consumer Services 15
Commercial Services 7
Electronic Technology 3
Finance 3

Opérationnelle

Director/Board Member 53
Corporate Officer/Principal 22
Undergraduate Degree 12
Independent Dir/Board Member 10
Chief Executive Officer 10
  1. Bourse
  2. Insiders
  3. Chris Williams
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT